Mangrove Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
SL
ACM
CS
WP
Mangrove Partners's NBP Position: Q1 2026 in Review
Mangrove Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 26,026 shares — an estimated $104K sold.
Mangrove Partners first reported a position in NBP in Q4 2025 and held it in 1 quarter. The position peaked at $104K in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.
- Mangrove Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
- Mangrove Partners sold 26,026 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $104K.
- Mangrove Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and held it in 1 quarter.
- Mangrove Partners's NovaBridge Biosciences American Depositary Shares position peaked at $104K in Q4 2025.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.
Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.